MWPCG
Measured Wealth Private Client Group’s Gilead Sciences GILD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $230K | Sell |
2,072
-11
| -0.5% | -$1.22K | 0.07% | 165 |
|
2025
Q1 | $233K | Sell |
2,083
-230
| -10% | -$25.8K | 0.07% | 154 |
|
2024
Q4 | $214K | Sell |
2,313
-137
| -6% | -$12.7K | 0.07% | 167 |
|
2024
Q3 | $205K | Buy |
+2,450
| New | +$205K | 0.07% | 172 |
|
2024
Q2 | – | Sell |
-4,977
| Closed | -$365K | – | 197 |
|
2024
Q1 | $365K | Sell |
4,977
-585
| -11% | -$42.9K | 0.13% | 122 |
|
2023
Q4 | $451K | Sell |
5,562
-8,369
| -60% | -$678K | 0.17% | 106 |
|
2023
Q3 | $1.04M | Buy |
13,931
+1,478
| +12% | +$111K | 0.42% | 34 |
|
2023
Q2 | $960K | Buy |
12,453
+1,923
| +18% | +$148K | 0.36% | 36 |
|
2023
Q1 | $874K | Buy |
10,530
+1,855
| +21% | +$154K | 0.34% | 40 |
|
2022
Q4 | $745K | Buy |
8,675
+3,864
| +80% | +$332K | 0.31% | 45 |
|
2022
Q3 | $297K | Buy |
+4,811
| New | +$297K | 0.13% | 105 |
|
2018
Q4 | – | Sell |
-1,216
| Closed | -$95K | – | 334 |
|
2018
Q3 | $95K | Buy |
+1,216
| New | +$95K | 0.06% | 240 |
|